Grantham, Mayo, Van Otterloo & Co (GMO)’s Stoneridge SRI Stock Holding History
Bought
Maintained
Sold
Other funds holding SRI
CB
FCM
PM
Grantham, Mayo, Van Otterloo & Co (GMO)'s SRI Position: Q3 2021 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Stoneridge (SRI) in Q3 2021, closing a stake of 57,200 shares — an estimated $1.69M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SRI in Q1 2018 and held it in 14 quarters. The position peaked at $8.24M in Q4 2019. 111 funds tracked by Wall St. Rank hold SRI as of Q3 2021.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Stoneridge position as of Q3 2021 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 57,200 Stoneridge shares in Q3 2021, an estimated $1.69M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Stoneridge in Q1 2018 and held it in 14 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Stoneridge position peaked at $8.24M in Q4 2019.
- 111 funds tracked by Wall St. Rank held Stoneridge as of Q3 2021.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2021, filed 12 Nov 2021.